Top

Published in:

01-01-2022 | SARS-CoV-2 | Review

Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients

Author: Shobi Veleri

Published in: Experimental Brain Research | Issue 1/2022

Abstract

The devastating COVID-19 pandemic is caused by the SARS-CoV-2 virus. It primarily affects the lung and induces acute respiratory distress leading to a decrease in oxygen supply to the cells. This lung insufficiency caused by SARS-CoV-2 virus contributes to hypoxia which can affect the brain and other organ systems. The heightened cytokine storm in COVID-19 patients leads to an immune reaction in the vascular endothelial cells that compromise the host defenses against the SARS-CoV-2 virus in various organs. The vascular endothelial cell membrane breach allows access for SARS-CoV-2 to infect multiple tissues and organs. The neurotropism of spike protein in SARS-CoV-2 rendered by furin site insertion may increase neuronal infections. These could result in encephalitis and encephalopathy. The COVID-19 patients suffered severe lung deficiency often showed effects in the brain and neural system. The early symptoms include headache, loss of smell, mental confusion, psychiatric disorders and strokes, and rarely encephalitis, which indicated the vulnerability of the nervous system to SARS-CoV-2. Infection of the brain and peripheral nervous system can lead to the dysfunction of other organs and result in multi-organ failure. This review focuses on discussing the vulnerability of the nervous system based on the pattern of expression of the receptors for the SARS-CoV-2 and the mechanisms of its cell invasion. The SARS-CoV-2 elicited immune response and host immune response evasion are further discussed. Then the effects on the nervous system and its consequences on neuro-sensory functions are discussed. Finally, the emerging information on the overall genetic susceptibility seen in COVID-19 patients and its implications for therapy outlook is discussed.

Andersen KG et al (2020) The proximal origin of SARS-CoV-2. Nat Med 26(4):450–452PubMedCrossRef

Banales JM et al (2019) Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol 16(5):269–281PubMedPubMedCentralCrossRef

Banerjee AK et al (2020) SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell 183(5):1325-1339e21PubMedPubMedCentralCrossRef

Barakat W et al (2014) Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade. Eur J Pharmacol 724:43–50PubMedCrossRef

Bergmann CC, Lane TE, Stohlman SA (2006) Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 4(2):121–132PubMedPubMedCentralCrossRef

Bernard-Valnet R et al (2020) Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur J Neurol 27(9):e43–e44CrossRefPubMed

Bilaloglu S et al (2020) Thrombosis in hospitalized patients with COVID-19 in a New York City Health System. JAMA 324(8):799–801PubMedPubMedCentralCrossRef

Bolaji P et al (2020) Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease. BMJ Case Rep 13(8):e236820PubMedPubMedCentralCrossRef

Bongrand P (1998) Specific and nonspecific interactions in cell biology. J Dispers Sci Technol 19(6–7):963CrossRef

Bosch BJ et al (2003) The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77(16):8801–8811PubMedPubMedCentralCrossRef

Bost P et al (2020) Host-viral infection maps reveal signatures of severe COVID-19 patients. Cell 181(7):1475-1488e12PubMedPubMedCentralCrossRef

Bradley BT et al (2020) Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet 396(10247):320–332PubMedPubMedCentralCrossRef

Brann DH et al (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 6(31):eabc5801PubMedCrossRef

Broer S et al (2008) Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. J Clin Invest 118(12):3881–3892PubMedPubMedCentralCrossRef

Cantuti-Castelvetri L et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370(6518):856–860PubMedPubMedCentralCrossRef

Carsana L et al (2020) Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 20(10):1135–1140PubMedPubMedCentralCrossRef

Cavalcante-Silva LHA et al (2021) Neutrophils and COVID-19: the road so far. Int Immunopharmacol 90:107233PubMedCrossRef

Chau TN et al (2004) SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 39(2):302–310PubMedCrossRef

Chen R et al (2020) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 11:573095PubMedCrossRef

Chen L et al (2020a) Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20(4):398–400PubMedPubMedCentralCrossRef

Chen L et al (2020b) Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol Immunol 17(9):992–994PubMedCrossRef

Cheng J et al (2019) The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of neurotropism. Viruses 11(10):972PubMedCentralCrossRef

Cheng Y et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829–838PubMedPubMedCentralCrossRef

Cheng J et al (2021) The furin-S2’ site in avian coronavirus plays a key role in central nervous system damage progression. J Virol 95:e02447PubMedCentralCrossRef

Cho K et al (2018) Heterozygous mutations in OAS1 cause infantile-onset pulmonary alveolar proteinosis with hypogammaglobulinemia. Am J Hum Genet 102(3):480–486PubMedPubMedCentralCrossRef

Conde Cardona G et al (2020) Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci 412:116824PubMedPubMedCentralCrossRef

Consortium WHOST (2021) Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results. N Engl J Med 384(6):497–511CrossRef

Coolen T et al (2020) Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology 95(14):e2016–e2027PubMedCrossRef

Cui C et al (2021) AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells. IEEE/ACM Trans Comput Biol Bioinform 18(4):1230–1233PubMedCrossRef

Cummings MJ et al (2020) Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 395(10239):1763–1770PubMedPubMedCentralCrossRef

Dai J et al (2019) Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir Med 7(10):881–891PubMedPubMedCentralCrossRef

Dalager-Pedersen M et al (2014) Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation 129(13):1387–1396PubMedCrossRef

Dantzer R (2018) Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev 98(1):477–504PubMedCrossRef

Dendrou CA et al (2016) Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. Sci Transl Med 8(363):363ra149PubMedPubMedCentralCrossRef

Deng J et al (2021) The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann NY Acad Sci 1486(1):90–111PubMedCrossRef

Desforges M et al (2007) Activation of human monocytes after infection by human coronavirus 229E. Virus Res 130(1–2):228–240PubMedPubMedCentralCrossRef

Diao B et al (2020) Reduction and functional exhaustion of T cells in patients with Coronavirus Disease 2019 (COVID-19). Front Immunol 11:827PubMedPubMedCentralCrossRef

Diao B et al (2021) Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun 12(1):2506PubMedPubMedCentralCrossRef

Dosch SF, Mahajan SD, Collins AR (2009) SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro. Virus Res 142(1–2):19–27PubMedPubMedCentralCrossRef

Dube M et al (2018) Axonal transport enables neuron-to-neuron propagation of human Coronavirus OC43. J Virol 92(17):e00404PubMedPubMedCentralCrossRef

Duong L, Xu P, Liu A (2020) Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun 87:33PubMedPubMedCentralCrossRef

Efe IE et al (2020) COVID-19-associated encephalitis mimicking glial tumor. World Neurosurg 140:46–48PubMedPubMedCentralCrossRef

Ellul MA et al (2020) Neurological associations of COVID-19. Lancet Neurol 19(9):767–783PubMedPubMedCentralCrossRef

Ely EW et al (2001) Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286(21):2703–2710PubMedCrossRef

Erickson MA, Banks WA (2018) Neuroimmune axes of the blood-brain barriers and blood-brain interfaces: bases for physiological regulation, disease states, and pharmacological interventions. Pharmacol Rev 70(2):278–314PubMedPubMedCentralCrossRef

Espindola OM et al (2021) Inflammatory cytokine patterns associated with neurological diseases in Coronavirus Disease 2019. Ann Neurol 89(5):1041–1045PubMedCrossRef

Fajgenbaum DC, June CH (2020) Cytokine Storm. N Engl J Med 383(23):2255–2273PubMedPubMedCentralCrossRef

Fan Z et al (2020) Clinical features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol 18(7):1561–1566PubMedPubMedCentralCrossRef

Feng P, Huang L, Wang H (2014) Taste bud homeostasis in health, disease, and aging. Chem Senses 39(1):3–16PubMedCrossRef

Ferrante L et al (2020) Brazil’s policies condemn Amazonia to a second wave of COVID-19. Nat Med 26(9):1315PubMedCrossRef

Fingerlin TE et al (2013) Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 45(6):613–620PubMedPubMedCentralCrossRef

Fliegauf M, Benzing T, Omran H (2007) When cilia go bad: cilia defects and ciliopathies. Nat Rev Mol Cell Biol 8(11):880–893PubMedCrossRef

Fridman S et al (2020) Stroke risk, phenotypes, and death in COVID-19: systematic review and newly reported cases. Neurology 95(24):e3373–e3385PubMedCrossRef

Gerdes JC et al (1981) Coronavirus isolates SK and SD from multiple sclerosis patients are serologically related to murine coronaviruses A59 and JHM and human coronavirus OC43, but not to human coronavirus 229E. J Virol 38(1):231–238PubMedPubMedCentralCrossRef

Giulio Sancini MG, Salvati E, Cambianica I, Re F, Ornaghi F, Canovi M, Fracasso C, Alfredo Cagnotto MC, Zona C, Gobbi M, Salmona M, La Ferla B, Nicotra F, Masserini M (2013) Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-b peptide. J Nanomed Nanotechol 4(1000171):1–8

Goshua G et al (2020) Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 7(8):e575–e582PubMedPubMedCentralCrossRef

Goyal P et al (2020) Clinical characteristics of Covid-19 in New York City. N Engl J Med 382(24):2372–2374PubMedCrossRef

Group R.C (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384(8):693–704CrossRef

Gutierrez-Ortiz C et al (2020) Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology 95(5):e601–e605PubMedCrossRef

Hacisuleyman E et al (2021) Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med 384(23):2212–2218PubMedCrossRef

Hadjadj J et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369(6504):718–724PubMedPubMedCentralCrossRef

Hampshire A et al (2021) Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39:101044PubMedPubMedCentralCrossRef

Harrison AG, Lin T, Wang P (2020) Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol 41(12):1100–1115PubMedPubMedCentralCrossRef

Hassanzadeh K et al (2020) Considerations around the SARS-CoV-2 spike protein with particular attention to COVID-19 brain infection and neurological symptoms. ACS Chem Neurosci 11(15):2361–2369PubMedCrossRef

Helms J et al (2020a) Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care 24(1):491PubMedPubMedCentralCrossRef

Helms J et al (2020b) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46(6):1089–1098PubMedCrossRefPubMedCentral

Helms J et al (2020c) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382(23):2268–2270PubMedCrossRef

Heneka MT et al (2020) Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 12(1):69PubMedPubMedCentralCrossRef

Hernández VS, Zetter MA, Guerra EC, Hernández-Araiza I, Karuzin N, Hernández-Pérez OR, Eiden LE, Zhang L (2021) ACE2 expression in rat brain: implications for COVID-19 associated neurological manifestations. Exp Neurol 345:113837. https://doi.org/10.1101/2021.05.01.442293

Hoelscher C et al (2020) Cerebral deep venous thrombosis and COVID-19: case report. J Neurosurg 135:1–4CrossRef

Hoffmann M et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280e8PubMedPubMedCentralCrossRef

Holmes D (2017) Repairing the neural highway. Nature 552(7684):S50–S51PubMedCrossRef

Hovnanian A et al (1998) The human 2’,5’-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. Genomics 52(3):267–277PubMedCrossRef

Huang I, Pranata R (2020) Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care 8:36PubMedPubMedCentralCrossRef

Huang J et al (2020a) Potential of SARS-CoV-2 to cause CNS infection: biologic fundamental and clinical experience. Front Neurol 11:659PubMedPubMedCentralCrossRef

Huang YH, Jiang D, Huang JT (2020b) SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun 87:149PubMedPubMedCentralCrossRef

Hughes S et al (2020) Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect 26(10):1395–1399PubMedPubMedCentralCrossRef

Iadecola C, Anrather J, Kamel H (2020) Effects of COVID-19 on the nervous system. Cell 183(1):16-27e1PubMedPubMedCentralCrossRef

Inciardi RM et al (2020) Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 41(19):1821–1829PubMedCrossRef

Initiative C-HG (2021) Mapping the human genetic architecture of COVID-19. Nature

James N, Menzies M, Radchenko P (2021) COVID-19 second wave mortality in Europe and the United States. Chaos 31(3):031105PubMedCrossRef

Jaywant A et al (2021) Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacol. https://doi.org/10.1038/s41386-021-00978-8

Kantonen J et al (2020) Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol 30(6):1012–1016PubMedPubMedCentralCrossRef

Kennedy M et al (2020) Delirium in older patients with COVID-19 presenting to the emergency department. JAMA Netw Open 3(11):e2029540PubMedPubMedCentralCrossRef

Klein DE et al (2020) Cerebral venous thrombosis: a typical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis 29(8):104989PubMedPubMedCentralCrossRef

Klok FA et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147PubMedPubMedCentralCrossRef

Kolilekas L et al (2020) Can steroids reverse the severe COVID-19 induced “cytokine storm”? J Med Virol 92(11):2866–2869PubMedCrossRef

Kopanska M et al (2021) Changes in EEG recordings in COVID-19 patients as a basis for more accurate QEEG diagnostics and EEG neurofeedback therapy: a systematic review. J Clin Med 10(6):1300PubMedPubMedCentralCrossRef

Koyuncu OO, Hogue IB, Enquist LW (2013) Virus infections in the nervous system. Cell Host Microbe 13(4):379–393PubMedPubMedCentralCrossRef

Lazartigues E, Qadir MMF, Mauvais-Jarvis F (2020) Endocrine significance of SARS-CoV-2’s reliance on ACE2. Endocrinology 161(9):bqaa108PubMedPubMedCentralCrossRef

Lee JS, Shin EC (2020) The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol 20(10):585–586PubMedCrossRefPubMedCentral

Lee SG, Fralick M, Sholzberg M (2020) Coagulopathy associated with COVID-19. CMAJ 192(21):E583PubMedPubMedCentralCrossRef

Lei F et al (2020) Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology 72(2):389–398PubMedCrossRef

Li Y, Xiao SY (2020) Hepatic involvement in COVID-19 patients: pathology, pathogenesis, and clinical implications. J Med Virol 92(9):1491–1494PubMedCrossRef

Li MY et al (2020a) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 9(1):45PubMedPubMedCentralCrossRef

Li YC, Bai WZ, Hashikawa T (2020b) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92(6):552–555PubMedCrossRef

Li Y et al (2020c) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5(3):279–284PubMedPubMedCentralCrossRef

Liu J et al (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55:102763PubMedPubMedCentralCrossRef

Lodigiani C et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9–14PubMedPubMedCentralCrossRef

Lopes-Pacheco M et al (2021) Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies. Front Physiol 12:593223PubMedPubMedCentralCrossRef

Lu S et al (2020) First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder. J Affect Disord 277:337–340PubMedPubMedCentralCrossRef

Luan G et al (2016) Upregulation of HMGB1, toll-like receptor and RAGE in human Rasmussen’s encephalitis. Epilepsy Res 123:36–49PubMedCrossRef

Lutfalla G et al (1995) Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J 14(20):5100–5108PubMedPubMedCentralCrossRef

Maas MB (2020) Critical medical illness and the nervous system. Continuum (minneap Minn) 26(3):675–694

Magro C et al (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 220:1–13PubMedPubMedCentralCrossRef

Mallapaty S (2021) India’s massive COVID surge puzzles scientists. Nature 592(7856):667–668PubMedCrossRef

Mao L et al (2020) Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 77(6):683–690CrossRefPubMed

Marjot T et al (2021) COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 18(5):348–364PubMedCrossRef

Masuo Y et al (2021) Smell and stress response in the brain: review of the connection between chemistry and neuropharmacology. Molecules 26(9):2571PubMedPubMedCentralCrossRef

Matloubian M et al (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1(4):298–304PubMedCrossRef

Maury A et al (2021) Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians. Rev Neurol (paris) 177(1–2):51–64CrossRef

Mawhinney JA et al (2020) Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode. BMJ Case Rep 13(6):e236123PubMedCrossRef

McAbee GN et al (2020) Encephalitis associated with COVID-19 infection in an 11-year-old child. Pediatr Neurol 109:94PubMedPubMedCentralCrossRef

Medeiros AK et al (2020) Higher frequency of hepatic steatosis at CT among COVID-19-positive patients. Abdom Radiol (NY) 45(9):2748–2754CrossRef

Mehta P et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034PubMedPubMedCentralCrossRef

Meinhardt J et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24(2):168–175PubMedCrossRef

Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20(6):355–362PubMedPubMedCentralCrossRef

Merkler AE et al (2020) Risk of ischemic stroke in patients with Coronavirus Disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol 78:497CrossRef

Middeldorp S et al (2020) Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 18(8):1995–2002PubMedPubMedCentralCrossRef

Middleton EA et al (2020) Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136(10):1169–1179PubMedCrossRef

Mokhtari T et al (2020) COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol 51(6):613–628PubMedPubMedCentralCrossRef

Moore JB, June CH (2020) Cytokine release syndrome in severe COVID-19. Science 368(6490):473–474CrossRefPubMed

Moores LK et al (2020) Prevention, diagnosis, and treatment of VTE in patients with Coronavirus Disease 2019: CHEST guideline and expert panel report. Chest 158(3):1143–1163PubMedCrossRef

Moriguchi T et al (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58PubMedPubMedCentralCrossRef

Moutal A et al (2021) SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. Pain 162(1):243–252PubMedCrossRef

Ou X et al (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11(1):1620PubMedPubMedCentralCrossRef

Oxley TJ et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60PubMedCrossRef

Pang HB et al (2014) An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability. Nat Commun 5:4904PubMedCrossRef

Paniz-Mondolfi A et al (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92(7):699–702PubMedCrossRef

Pendlebury ST, Rothwell PM, Oxford S (2019) Vascular, Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol 18(3):248–258PubMedPubMedCentralCrossRef

Perico L et al (2021) Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol 17(1):46–64PubMedCrossRef

Plein A, Fantin A, Ruhrberg C (2014) Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability. Microcirculation 21(4):315–323PubMedPubMedCentralCrossRef

Politi LS, Salsano E, Grimaldi M (2020) Magnetic resonance imaging alteration of the brain in a patient with Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol 77(8):1028–1029PubMedCrossRef

Qi F et al (2020) Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun 526(1):135–140PubMedPubMedCentralCrossRef

Qin C et al (2020) Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 71(15):762–768CrossRefPubMed

Ramlall V et al (2020) Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med 26(10):1609–1615PubMedPubMedCentralCrossRef

Reichard RR et al (2020) Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 140(1):1–6PubMedPubMedCentralCrossRef

Reiter ER et al (2020) Subjective smell and taste changes during the COVID-19 pandemic: Short term recovery. Am J Otolaryngol 41(6):102639PubMedPubMedCentralCrossRef

Rossaint J et al (2014) Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation. Blood 123(16):2573–2584PubMedCrossRef

Rostami M, Mansouritorghabeh H (2020) D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol 13(11):1265–1275PubMedCrossRef

Schultze JL, Aschenbrenner AC (2021) COVID-19 and the human innate immune system. Cell 184(7):1671–1692PubMedPubMedCentralCrossRef

Seo S et al (2011) A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened. PLoS Genet 7(11):e1002358PubMedPubMedCentralCrossRef

Shang J et al (2020) Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA 117(21):11727–11734PubMedPubMedCentralCrossRef

Shen B et al (2020) Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182(1):59-72e15PubMedPubMedCentralCrossRef

Shu T et al (2020) Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity 53(5):1108-1122e5PubMedPubMedCentralCrossRef

Smith EM et al (1999) IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol 100(1–2):140–148PubMedCrossRef

Smith ER et al (2005) A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol Cell Biol 25(21):9175–9188PubMedPubMedCentralCrossRef

Solomon IH et al (2020) Neuropathological features of Covid-19. N Engl J Med 383(10):989–992PubMedCrossRef

Song E et al (2021) Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218(3):e20202135PubMedPubMedCentralCrossRef

Spence JD et al (2020) Mechanisms of stroke in COVID-19. Cerebrovasc Dis 49(4):451–458PubMedCrossRef

Su H et al (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98(1):219–227PubMedPubMedCentralCrossRef

Suh YJ et al (2021) Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis. Radiology 298(2):E70–E80PubMedCrossRef

Sultan-Styne K et al (2009) Long-term survival of olfactory sensory neurons after target depletion. J Comp Neurol 515(6):696–710PubMedPubMedCentralCrossRef

Tilley AE et al (2015) Cilia dysfunction in lung disease. Annu Rev Physiol 77:379–406PubMedCrossRef

Toscano G et al (2020) Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med 382(26):2574–2576PubMedCrossRef

Tummino TA et al (2021) Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2. Science 373(6554):541–547PubMedCrossRefPubMedCentral

Underwood MD et al (1999) Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol Psychiatry 46(4):473–483PubMedCrossRef

Vankadari N, Wilce JA (2020) Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 9(1):601–604PubMedPubMedCentralCrossRef

Venkatesan A et al (2013) Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 57(8):1114–1128PubMedPubMedCentralCrossRef

Venketasubramanian N, Hennerici MG (2020) Stroke in COVID-19 and SARS-CoV-1. Cerebrovasc Dis 49(3):235–236PubMedCrossRef

Virhammar J et al (2020) Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology 95(10):445–449PubMedPubMedCentralCrossRef

von Hundelshausen P et al (2005) Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105(3):924–930CrossRef

Wan Y et al (2020) Receptor recognition by the Novel Coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS Coronavirus. J Virol 94(7):e00127PubMedPubMedCentralCrossRef

Wang K et al (2020a) CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 5(1):283PubMedPubMedCentralCrossRef

Wang L et al (2020b) Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients. World J Clin Cases 8(19):4370–4379PubMedPubMedCentralCrossRef

Wang D et al (2020c) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069PubMedPubMedCentralCrossRef

Wang L et al (2021) An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility. Genome Med 13(1):83PubMedPubMedCentralCrossRef

WHO (2021) WHO Coronavirus (COVID-19) Dashboard

Wilkerson RG et al (2020) Silent hypoxia: a harbinger of clinical deterioration in patients with COVID-19. Am J Emerg Med 38(10):2243e5-2243e6CrossRef

Xu H et al (2020) Clinical characteristics and risk factors of cardiac involvement in COVID-19. J Am Heart Assoc 9(18):e016807PubMedPubMedCentralCrossRef

Xu Z et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420–422PubMedPubMedCentralCrossRef

Yaghi S et al (2020) SARS-CoV-2 and stroke in a new york healthcare system. Stroke 51(7):2002–2011PubMedCrossRef

Yang L et al (2020) A Human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell 27(1):125–136PubMedPubMedCentralCrossRef

Ye M, Ren Y, Lv T (2020) Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun 88:945–946PubMedPubMedCentralCrossRef

Yeager CL et al (1992) Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357(6377):420–422PubMedPubMedCentralCrossRef

Zanin L et al (2020) SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (wien) 162(7):1491–1494CrossRef

Zeqing Feng BD, Rongshuai W, Gang W, Chenhui W, Yingjun T, Liang L, Changsong W, Ying L, Yueping L, Zilin Y, Liang R, Yuzhang W, Yongwen C (2020) The novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. https://doi.org/10.1101/2020.03.27.20045427

Zhang T et al (2016) CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med 22(2):175–182PubMedCrossRef

Zhang C et al (2020) Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease. J Biol Chem 295(36):12686–12696PubMedPubMedCentralCrossRef

Zhen L, Jiwei YMW, Jie G, Xiang L, Siji S, Jiali L, Guangjie D, Yuanxiu Z, Xiaojun W, Zhansong Z, Taojiao W, Ming H, Xianxiang C, Yu F, Chong L, Hailong D, Chuou X, Yahua H, Min H, Yi Z, Hongbo J, Xiaowei C, Junan Y (2020) Caution on Kidney Dysfunctions of COVID-19 Patients. https://doi.org/10.1101/2020.02.08.20021212

Zheng S et al (2020a) Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 369:m1443PubMedPubMedCentralCrossRef

Zheng YY et al (2020b) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17(5):259–260PubMedCrossRef

Zhou W, Wang Y (2016) Candidate genes of idiopathic pulmonary fibrosis: current evidence and research. Appl Clin Genet 9:5–13PubMedPubMedCentral

Zhou P et al (2020a) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273PubMedPubMedCentralCrossRef

Zhou Y et al (2020b) Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov 6(1):14PubMedPubMedCentralCrossRef

Zingg B et al (2020) Synaptic specificity and application of anterograde transsynaptic AAV for probing neural circuitry. J Neurosci 40(16):3250–3267PubMedPubMedCentralCrossRef

Zou X et al (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14(2):185–192PubMedCrossRef

Title: Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
Author: Shobi Veleri
Publication date: 01-01-2022
Publisher: Springer Berlin Heidelberg
Keywords: SARS-CoV-2
COVID-19
Encephalopathy
Stroke
Encephalitis
Published in: Experimental Brain Research / Issue 1/2022
Print ISSN: 0014-4819
Electronic ISSN: 1432-1106
DOI: https://doi.org/10.1007/s00221-021-06244-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Neural mechanism by which physical fatigue sensation suppresses physical performance: a magnetoencephalography study

Reciprocal and coactivation commands at the level of individual motor units in an extrinsic finger flexor–extensor muscle pair

Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson’s disease: involvement of anti-inflammatory response

The role of spatial acuity in a dynamic balancing task without gravitational cues

Partial visual loss disrupts the relationship between judged room size and sound source distance

The effect of cathodal transspinal direct current stimulation on tibialis anterior stretch reflex components in humans